novel
class
acetyl
fulli
deprotect
nacylbdglucopyranosylamin
urea
synthes
biolog
evalu
acyl
peroacetyl
bdglucopyranosylurea
easili
prepar
via
correspond
phosphinimin
deriv
zinc
chlorid
catalyz
reaction
correspond
acyl
chlorid
rcocl
af
gave
protect
nacylbdglucopyranosylurea
acceptabletomoder
yield
subsequ
deacetyl
analogu
condit
afford
fulli
deprotect
deriv
b
e
f
desir
urea
form
treatment
dibutyltin
oxid
protect
unprotect
compound
examin
cytotox
activ
differ
cem
hela
tumor
cell
line
also
evalu
broad
panel
dma
rna
virus
deriv
exhibit
cytostat
activ
three
evalu
tumor
cell
line
ic
might
basi
synthesi
structurerel
deriv
improv
cytostat
potenti
analogu
weakli
significantli
inhibit
replic
viru
sindbi
viru
coxsacki
viru
cell
cultur
concentr
lm
cancer
figur
among
major
concern
modern
healthcar
due
rapidli
increas
rate
associ
mortal
light
grow
preval
malign
carcinoma
implic
equal
impetu
paid
scientif
commun
research
diseas
ferlay
et
al
although
signific
effort
made
improv
current
prevent
andor
therapeut
strategi
carcinogenesi
develop
new
select
agent
capabl
suppress
tumor
growth
metastasi
would
contribut
greatli
better
prognosi
current
therapi
sethi
kang
begin
lu
et
al
small
molecul
kinas
inhibitor
shown
great
potenti
novel
therapeut
treatment
cancer
sausvil
intim
involv
oncogen
signal
transduct
pathway
present
multipl
physiolog
respons
tumor
cell
prolifer
cell
surviv
blanc
et
al
among
sorafenib
nevaxar
diaryl
urea
analogu
small
molecular
inhibitor
sever
tyrosin
protein
kinas
treatment
advanc
renal
cell
carcinoma
rcc
advanc
hepatocellular
carcinoma
hcc
wilhelm
et
al
montagut
settleman
manner
bear
nacylhydrazon
pharmacophor
promis
new
antitumor
drug
directli
influenc
apoptot
machineri
suicid
cell
shown
good
result
mous
model
zhang
et
al
peterson
et
al
putt
et
al
final
carboxamid
analogu
sunitinib
sutent
proven
success
treatment
renal
cancer
pancreat
neuroendocrin
tumor
thiazol
carboxamid
analogu
dasatinib
use
treatment
sever
type
leukemia
et
al
probabl
use
amid
urea
heteroatom
linker
nitrogen
oxygen
structur
aforement
inhibitor
import
featur
select
allow
format
one
two
hydrogen
bond
residu
specif
kinas
davi
et
al
view
observ
continu
longterm
interest
glucopyranosyl
analogu
antitumorantivir
agent
potent
enzym
inhibitor
parmenopoul
et
al
dimopoul
et
al
manta
et
al
kantsadi
et
al
envisag
compound
bear
glucopyranosyl
moieti
link
variou
aralkyl
aralkenyl
group
et
al
b
via
pharmacophor
linker
nhco
nhconhco
would
endow
pronounc
antitumor
activ
herebi
report
facil
synthesi
biolog
properti
novel
acetyl
well
fulli
deprotect
nacylbdglucopyranosylamin
urea
respect
chemistri
synthesi
target
nacyln
peroacetyl
bdglucopyranosylurea
easili
prepar
via
correspond
phosphinimin
deriv
pinter
et
al
seem
suitabl
precursor
therefor
acyl
compound
pinter
et
al
zinc
chlorid
zncl
catalyz
reaction
correspond
acyl
chlorid
rcocl
af
gave
deriv
acceptabletomoder
yield
although
lewi
acid
zinc
chlorid
activ
acid
chlorid
also
catalyz
iminium
ion
format
paulsen
pflufhaupt
isbel
frush
therebi
anomer
et
al
b
case
banom
sole
obtain
hz
j
c
hz
j
c
hz
aris
transdiaxi
orient
consecut
proton
indic
bconfigur
sugar
moieti
equatori
orient
acetyl
group
subsequ
deacetyl
analogu
condit
agoston
et
al
min
afford
fulli
deprotect
deriv
b
e
f
flash
chromatographi
good
yield
deprotect
acyl
urea
either
basic
acid
transesterif
condit
sodium
methoxid
methanol
ammonia
methanol
hydrogen
chlorid
unsuccess
due
faster
cleavag
nacyl
moieti
remov
oprotect
group
order
overcom
difficulti
success
synthes
compound
sought
coupl
free
glucosyl
urea
mckay
nguyen
helm
kakhesi
desir
acyl
chlorid
rcocl
c
presenc
zncl
unfortun
start
materi
recov
delight
acyl
urea
stir
methanol
presenc
eq
dibutyltin
oxid
bu
sno
reflux
liu
et
al
acetyl
group
smoothli
deprotect
deriv
isol
flash
chromatographi
yield
scheme
compound
well
character
h
c
nmr
mass
spectrometri
element
analysi
gave
satisfactori
analyt
spectroscop
data
full
accord
depict
structur
spectroscop
character
compound
appear
consist
two
rotam
judg
h
nmr
spectra
probabl
due
hinder
rotat
amid
bond
cytostat
activ
determin
murin
leukemia
human
lymphocyt
cem
human
cervix
carcinoma
hela
cell
cultur
result
summar
tabl
overal
result
obtain
clear
acetyl
nacylbdglucopyranosylamin
urea
b
e
f
show
better
cytostat
profil
correspond
unprotect
deriv
b
e
f
respect
tabl
except
analogu
prove
cytostat
correspond
acetyl
congen
particular
deriv
prove
cytotox
three
tumor
cell
line
ic
respect
cytostat
potenti
lower
establish
anticanc
drug
final
acetyl
analogu
unprotect
exhibit
compar
degre
cellular
cytotox
ic
also
test
compound
cytotox
normal
primari
confluent
human
lung
fibroblast
hel
cell
cultur
mcc
compound
acetyl
glucopyranosyl
urea
found
inhibit
prolifer
viru
sindbi
viru
coxsacki
viru
vero
cell
concentr
lm
vide
ic
respect
wherea
welldescrib
antivir
drug
ribavirin
show
activ
lm
polyanion
compound
dextran
sulfat
ds
mw
also
includ
control
compound
tabl
studi
report
synthesi
novel
acetyl
well
fulli
deprotect
nacylbdglucopyranosylamin
urea
potenti
cytotox
agent
sinc
nacylbdglucopyranosylurea
prove
cytostat
correspond
amin
final
analogu
less
potent
acetyl
congen
seem
cytostat
activ
compound
associ
type
linker
acetyl
moieti
may
also
contribut
antitumor
effect
deriv
exhibit
enhanc
cytostat
activ
ic
respect
might
basi
prepar
structurerel
deriv
improv
cytostat
potenti
analogu
inhibit
prolifer
viru
sindbi
viru
coxsacki
viru
vero
cell
cultur
concentr
lm
vide
ic
respect
compar
ribavirin
lm
thin
layer
chromatographi
tlc
perform
merck
precoat
plate
reaction
monitor
tlc
mass
spectra
obtain
thermoquest
finnigan
aqa
mass
spectromet
electrospray
ioniz
optic
rotat
measur
use
autopol
polarimet
reaction
sensit
oxygen
moistur
carri
nitrogen
atmospher
use
ovendri
glasswar
chloroform
chcl
distil
phosphoru
pentoxid
store
molecular
siev
methanol
meoh
store
molecular
siev
azid
tropper
et
al
nacylbdglucopyranosylamin
parmenopoul
et
al
pinter
et
al
prepar
accord
procedur
describ
literatur
chemic
physic
properti
agreement
previou
data
gener
procedur
prepar
nacyln
solut
acyl
chlorid
mmol
ml
dri
chcl
anhydr
zncl
mmol
mmol
ad
stir
reaction
mixtur
reflux
tlc
show
complet
transform
urea
reaction
mixtur
pour
ice
water
extract
chloroform
organ
phase
collect
wash
sat
aq
nahco
solut
water
dri
solvent
evapor
vacuo
residu
purifi
flash
chromatographi
nhexaneetoac
hz
dd
j
hz
ddd
j
hz
c
nmr
mhz
cdcl
co
ococh
h
n
found
c
h
n
co
tetrahydronaphthalen
moieti
c
h
n
found
c
h
n
arh
j
hz
arh
j
hz
j
hz
q
j
hz
ch
dd
j
hz
dd
j
hz
ddd
j
hz
c
nmr
mhz
cdcl
co
ococh
n
found
c
h
n
etc
lm
test
compound
viral
cytopath
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopathogen
viral
plaqu
vzv
plaqu
format
minim
cytotox
concentr
mcc
compound
defin
compound
concentr
caus
microscop
visibl
alter
cell
morpholog
altern
cytostat
activ
test
compound
measur
base
inhibit
cell
growth
hel
cell
seed
rate
cellswel
microtit
plate
allow
prolifer
h
medium
contain
differ
concentr
test
compound
ad
three
day
incub
cell
number
determin
coulter
counter
cytostat
concentr
calcul
cc
compound
concentr
requir
reduc
cell
prolifer
rel
number
cell
untreat
control
methodolog
antihiv
assay
follow
human
cem
cellscm
cell
infect
ccid
seed
well
microtit
plate
contain
appropri
dilut
test
compound
day
incub
hivinduc
cem
giant
cell
format
examin
light
microscop
antiprolif
assay
novikov
et
al
cytostat
effect
test
compound
murin
leukemia
cell
human
tlymphocyt
cell
cem
human
cervix
carcinoma
cell
hela
evalu
follow
appropri
number
cell
suspend
growth
medium
allow
prolifer
microtit
plate
presenc
variabl
amount
test
compound
humidifi
co
control
atmospher
h
h
cem
h
hela
number
cell
determin
coulter
counter
ic
valu
defin
compound
concentr
requir
inhibit
cell
prolifer
cytotox
activ
assay
novikov
et
al
confluent
human
lung
fibroblast
hel
cultur
microtit
plate
expos
serial
dilut
test
compound
ie
day
incub
microscop
detect
alter
cell
morpholog
examin
